9DC Stock Overview
Engages in the materials, medical/healthcare, smart, safety, engineering plastics, and other businesses in Japan, China, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 2/6 |
| Past Performance | 4/6 |
| Financial Health | 4/6 |
| Dividends | 4/6 |
Daicel Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥8.20 |
| 52 Week High | JP¥9.55 |
| 52 Week Low | JP¥6.75 |
| Beta | 0.46 |
| 11 Month Change | 2.50% |
| 3 Month Change | 1.23% |
| 1 Year Change | -4.65% |
| 33 Year Change | 30.16% |
| 5 Year Change | -7.34% |
| Change since IPO | -28.70% |
Recent News & Updates
Recent updates
Shareholder Returns
| 9DC | DE Chemicals | DE Market | |
|---|---|---|---|
| 7D | 1.2% | -1.3% | -1.3% |
| 1Y | -4.7% | -1.6% | 7.4% |
Return vs Industry: 9DC underperformed the German Chemicals industry which returned -1.2% over the past year.
Return vs Market: 9DC underperformed the German Market which returned 7.1% over the past year.
Price Volatility
| 9DC volatility | |
|---|---|
| 9DC Average Weekly Movement | 3.3% |
| Chemicals Industry Average Movement | 4.2% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.8% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 9DC has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: 9DC's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1919 | 11,134 | Yoshimi Ogawa | www.daicel.com |
Daicel Corporation engages in the materials, medical/healthcare, smart, safety, engineering plastics, and other businesses in Japan, China, and internationally. The company offers acetic acid, acetic acid derivative chemicals, acetate tow, acetic anhydride, thioglycolic acid, caprolactone derivatives, methyl 3-methoxyacrylate, cycloaliphatic epoxies, alkylamines comprising diethylhydroxyamine, and 1,3-butylene glycol, as well as cellulose acetate; and Actranza Lab, a drug delivery device. It also provides solutions for the electronics market, such as functional films and materials for use in smartphones, PCs, TVs, and in-vehicle displays; polymers and solvents for use in the semiconductor manufacturing process; optical lenses for use in VR, smartphones, and various sensors; printed electronic materials; and organic semiconductors.
Daicel Corporation Fundamentals Summary
| 9DC fundamental statistics | |
|---|---|
| Market cap | €2.26b |
| Earnings (TTM) | €358.96m |
| Revenue (TTM) | €3.56b |
6.3x
P/E Ratio0.6x
P/S RatioIs 9DC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 9DC income statement (TTM) | |
|---|---|
| Revenue | JP¥576.74b |
| Cost of Revenue | JP¥408.39b |
| Gross Profit | JP¥168.35b |
| Other Expenses | JP¥110.21b |
| Earnings | JP¥58.14b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 214.31 |
| Gross Margin | 29.19% |
| Net Profit Margin | 10.08% |
| Debt/Equity Ratio | 71.9% |
How did 9DC perform over the long term?
See historical performance and comparisonDividends
4.4%
Current Dividend Yield12%
Payout RatioDoes 9DC pay a reliable dividends?
See 9DC dividend history and benchmarks| Daicel dividend dates | |
|---|---|
| Ex Dividend Date | Sep 27 2024 |
| Dividend Pay Date | Dec 03 2024 |
| Days until Ex dividend | 57 days |
| Days until Dividend pay date | 10 days |
Does 9DC pay a reliable dividends?
See 9DC dividend history and benchmarks